Mriglobal

Full sourced report, $150 one time

Run this nonprofit?

Your page is already built from your 990.

Claim it free to add your story, photos and a give link.

Are you Ian M Colrain PhD? The 2024 Form 990 lists you as President and CEO. Claim this page free. About 2 minutes

To improve the lives of people through innovative scientific and engineering research.

Form 990 Part I, line 1, FY2025. The organization’s own words, as filed with the IRS. Find it at the IRS (EIN 44-0545878) · Dispute this line
FORM 990 2025 FY ending September 2025

Total revenue $115.8M in FY2025 Latest return filed Jun 12, 2026

501(c)(3) charity; gifts are tax-deductible.
78¢ of each $1 spent went to programs.
$5.9M paid to officers and key staff.
Mission: Form 990 Part I, line 1 · Status: IRS Pub. 78 · Programs: Part IX · Pay: Part VII

What it does

3 programs · $95.4M · in their own filed words · FY2025
01

Integrated Defense Solutions

MRIGlobal guards human health and safety by defending against chemical, biological, and explosive threats. With decades of chemical warfare agent detection, evaluation, and assessment, our unique expertise and history combines scientific and engineering experts with state-of-the-art laboratory facilities to advance programs across the…

Form 990 Part III, line 4, FY2025. The organization’s own words, as filed with the IRS. Find it at the IRS (EIN 44-0545878) · Dispute this line
$42.1Mprogram expense
02

Integrated Health Surveillance and Diagnostics

MRIGlobal performs research to counter threats to human health. In our world-class laboratories, our team supports all phases of immuno and molecular assays in our CAP/CLIA certified labs. Our capabilities range from the development of cutting-edge molecular and immunological assays focused on emerging highly infectious diseases…

Form 990 Part III, line 4, FY2025. The organization’s own words, as filed with the IRS. Find it at the IRS (EIN 44-0545878) · Dispute this line
$36.4Mprogram expense
03

Integrated Pharmaceutical Solutions

MRIGlobal bridges the gap between drug discovery and commercialization. We provide the necessary services including development, manufacturing, testing, and clinical trial material management support for drug substances, drug products, intermediates, and impurities, including reference standard materials.

Form 990 Part III, line 4, FY2025. The organization’s own words, as filed with the IRS. Find it at the IRS (EIN 44-0545878) · Dispute this line
$17.0Mprogram expense

Before you give

FY2025 · Form 990Independent: from IRS data, not the org
Download 990
IRS status
501(c)(3)
not on the IRS revocation list
Listed by the IRS and not on the revocation list.
IRS BMF · Auto-Revocation List
Tax-deductible gifts
Yes
Donations are tax-deductible
The IRS lists gifts to it as deductible.
IRS Pub. 78 · IRS BMF
Latest return
FY2025
latest Form 990
The latest return is for FY2025, current with the IRS.
IRS e-file · Filing history
Surplus or deficit
5 of 6
filings with a surplus
Average surplus $4.5M a year · 4% of revenue · last 6 filings
A surplus in 5 of the last 6 filings.
Pt I · Ln 19 · 6 filings
Spent on programs
78%
of spending
78% of spending went to programs.
Pt IX · Ln 25 · col B
Pay to officers and key staff
$5.9M
to officers and key staff · 5% of spending
Pay to officers and key staff is 5% of spending.
Part VII, Section A
5.2 mo
of spending, in cash
5.2 months of spending in cash.
Pt X · Ln 1–2 · Pt I · Ln 18
Named funders
8
named funders · $2.8M · 2019–2024
8 funders name it on their filings.
Funders’ Sch. I, 990-PF
Liabilities
$29.0M
21% of total assets
Liabilities are 21% of assets.
Pt X · Ln 26
Independent board members
14
of 15 voting members
14 of 15 voting members are independent.
Pt VI · Ln 1a–1b
Audited financial statements
Yes
audited by an independent accountant
An independent accountant audited the financial statements.
Pt XII · Ln 2b
Total revenue
$115.8M
-2% vs prior year
Total expenses
$121.8M
To programs
78%
Net assets
$111.0M
By yearFY2020–FY2025
Revenue
$115.8M
FY2025▼ -2%
Tap a bar for its year
Revenue by fiscal year
FY2020$102.7M
FY2021$116.1M
FY2022$128.6M
FY2023$119.6M
FY2024$118.0M
FY2025$115.8M
Expenses
$121.8M
FY2025▲ +6%
Tap a bar for its year
Expenses by fiscal year
FY2020$95.1M
FY2021$107.6M
FY2022$121.2M
FY2023$112.9M
FY2024$115.3M
FY2025$121.8M
Net assets
$111.0M
FY2025+0.2%
Tap a bar for its year
Net assets by fiscal year
FY2020$51.0M
FY2021$69.6M
FY2022$88.2M
FY2023$102.8M
FY2024$110.8M
FY2025$111.0M

From the FY2025 Form 990 (year ending September 2025) · figures checked against the IRS filing · see the original

Is it real?

Yes. Never revoked by the IRS. Latest filing on record: FY2025. IRS ruling in Jul 1946.

IRS Pub. 78 · IRS Auto-Revocation List · IRS Business Master File

Where the money goes

78 cents of each dollar spent went to programs.

Program services 78% · $95.4M Management & general 22% · $26.4M

Form 990 Part IX, line 25, columns B–D. Every line is in By the numbers.

Something off? Claim to add context

Who runs it and what they're paid

31 people listed on the 990; $5.9M paid to officers and key staff (Part VII, Section A).

Part VII, Section A · reportable compensation
President and CEO
Hours a week: 40
$943,691Pt VII · Sec A
CFO and Treasurer - Outgoing
Hours a week: 40
$509,061Pt VII · Sec A
Chief Innovation Officer
Hours a week: 40
$400,380Pt VII · Sec A
Chief People Officer
Hours a week: 40
$370,224Pt VII · Sec A
Chief Legal Officer & Corp Secretary
Hours a week: 40
$364,629Pt VII · Sec A
Vp-Commercial Business Development
Hours a week: 40
$353,318Pt VII · Sec A
Chief Research Fellow
Hours a week: 40
$343,045Pt VII · Sec A
Vp-Government Business Development
Hours a week: 40
$300,450Pt VII · Sec A

Ian M Colrain PHD’s $944K as President and CEO is at the 56th percentile of top reported officer pay among 43 $100M+ science & technology nonprofits. Peer set: organizations in the same NTEE major field of work and revenue-size band, compared on each org’s own highest-paid officer/key-employee, from Form 990 Part VII / 990-PF Part VIII. Descriptive placement, not a verdict on whether the pay is appropriate.

Compensation history total reportable pay by year · 8 named individuals · Part VII

NameFY2025FY2024FY2023FY2022FY2021FY2020
Thomas M Sack——$391,881$1,059,526$970,250$943,623
Ian M Colrain PHD$943,691$651,041$573,720———
Richard T Fleener—$412,881$333,630$514,469$659,544$566,858
Reachel a Beichley—$645,171$387,353$514,307$449,517$441,706
Martin J Nevshemal$509,061$469,983$308,580$360,819$304,595—
Robert a Conklin—$149,711$413,824$392,476$358,666$310,384
Amy M Bog PHD$400,380$332,673$78,506———
Dean E Gray—$222,009$336,943$381,306$278,944$238,696

Total reportable compensation (Form 990 Part VII column D / Schedule J column E) by filing year, matched by name within this organization, with a nickname or small spelling change read as the same person. The Schedule J base / bonus / deferred breakdown is not parsed into this dataset.

See Mriglobal executive salaries →

Questions the 990 asks

The form asks each of these directly. These are the filed answers.

  • Family or business ties among officersPt VI · Ln 2Yes
  • Top official's pay set by an independent reviewPt VI · Ln 15aYes

Updates and questions

Develops science and technology solutions for a safer, healthier, and more sustainable world.

Our summary of the filed mission and programs (Form 990 Part III, line 4), not the words of the organization.

Questions for Mriglobal

Tap to ask. Questions wait here until someone from Mriglobal claims this page.

Your first name shows with your question. Nobody from Mriglobal has claimed this page yet, so no one there sees or answers questions until they do.

Funders

Who pays for it.

From grant filings on record. Receipts are incomplete: individual donors are never listed.

Grants

Schedule I · received and paid
Grants received · from the funders’ 2024 returns

Dated by each funder’s own filing year, which may not match this organization’s fiscal year.

Total grants received, 2019–2024from 8 funders$2.8M
See all 8 funders, 2019–2024 →
Grants paid · 10 grants · $425K · 2019–2024
Bionexus KcMO · FY2021$50,000
Bionexus KcMO · FY2020$50,000
Bionexus KcMO · FY2019$50,000

Federal money

Single Audit · Federal Audit Clearinghouse · money spent from federal programs · USAspending
Year ending Sep 2025 · $77.0M federal money spent
Research and Development ClusterDepartment of Defense · ALN 12.RD · Direct and through Advanced Technology International (ati) and 6 more$49.6M
Research and Development ClusterDepartment of Health and Human Services · ALN 93.RD · Direct and through The Ohio State University and 4 more$20.2M
Research and Development ClusterOther federal agency · ALN 99.RD · Direct and through National Strategic Research Institute (nsri) and 2 more$4.7M
Research and Development ClusterDepartment of Homeland Security · ALN 97.RD · Direct and through Zeteo Tech$1.8M
Congressional DirectivesDepartment of Health and Human Services · ALN 93.493 · Direct$384K

Plus 3 smaller programs.

The auditor reported no findings.

Year ending Sep 2024 · $71.4M federal money spent
Research and Development ClusterDepartment of Defense · ALN 12.RD · Direct and through Advanced Technology International (ati) and 4 more$52.3M
Research and Development ClusterDepartment of Health and Human Services · ALN 93.RD · Direct and through Uc San Diego School of Medicine and 1 more$12.5M
Research and Development ClusterOther federal agency · ALN 99.RD · Direct and through National Strategic Research Institute (nsri)$5.2M
Research and Development ClusterDepartment of Homeland Security · ALN 97.RD · Direct$944K
Research and Development ClusterDepartment of the Interior · ALN 15.RD · Through Sri International$322K

Plus 1 smaller program.

The auditor reported 40 findings.

Year ending Sep 2023 · $71.4M federal money spent
Research and DevelopmentDepartment of Defense · ALN 12.RD · Direct and through Advanced Technology International (ati) and 1 more$54.1M
Research and DevelopmentDepartment of Health and Human Services · ALN 93.RD · Direct and through Uc San Diego School of Medicine and 1 more$11.6M
Research and DevelopmentOther federal agency · ALN 99.RD · Direct and through Cherokee Nat$3.6M
Congressional DirectivesDepartment of Health and Human Services · ALN 93.493 · Direct$1.8M
Research and DevelopmentDepartment of Homeland Security · ALN 97.RD · Direct$287K

Plus 2 smaller programs.

The auditor reported 41 findings.

Year ending Sep 2022 · $70.8M federal money spent
NADepartment of Defense · ALN 12.RD · Direct and through Advanced Technology International (ati) and 2 more$51.0M
Hhsn273201400020cDepartment of Health and Human Services · ALN 93.RD · Direct and through Uc San Diego School of Medicine and 2 more$13.0M
B15-2015140g006Other federal agency · ALN 99.RD · Direct and through Cherokee Nat$6.3M
19AQMM20C0213Department of State · ALN 19.RD · Direct$334K
Dtfh61-13-H-00024Department of Transportation · ALN 20.RD · Direct and through Roadway Safety Foundation$179K

Plus 1 smaller program.

The auditor reported 8 findings.

About 66% of its revenue in the year ending Sep 2025 was federal money it spent ($77.0M of $115.8M).

Awards signed straight to it, by federal fiscal year (Oct to Sep), the last 5 years with money and the top agencies. An award is money promised, not money spent: one award can pay out over several years, so these do not add up to the money spent above. Money that came through a state or another group is not counted here. Last pulled from USAspending Nov 6, 2026.

Federal fiscal year 2026 · $48.3M in awards signed (not money spent) · grants $7.5M, contracts $40.8M
Department of Health and Human Services$24.7M
Department of Defense$18.3M
Department of Homeland Security$4.6M
Federal fiscal year 2025 · $51.7M in awards signed (not money spent) · contracts $51.7M
Department of Defense$21.0M
Department of Health and Human Services$15.1M
Environmental Protection Agency$13.0M
Federal fiscal year 2024 · $35.2M in awards signed (not money spent) · grants $500K, contracts $34.7M
Department of Defense$16.9M
Department of Health and Human Services$16.5M
Department of Homeland Security$1.7M
Federal fiscal year 2023 · $71.3M in awards signed (not money spent) · grants $1.0M, contracts $70.3M
Department of Defense$41.7M
Department of Health and Human Services$26.4M
Department of Homeland Security$2.2M
Federal fiscal year 2022 · $49.5M in awards signed (not money spent) · grants $2.0M, contracts $47.5M
Department of Defense$31.7M
Department of Health and Human Services$16.5M
Department of Agriculture$863K

By the numbers

The FY2025 990, line by line.

1The main four
Money inPt VIII
$115.8M
Ln 12
Gifts and grantsLn 1h$87.5M
Fees for servicesLn 2g$26.1M
Investment incomeLn 3$2.1M
Money outPt IX
$121.8M
Ln 25
Programscol B$95.4M
Managementcol C$26.4M
Owns and owesPt X
$111.0M
net assets · Ln 32
Cash and savingsLn 1–2$52.5M
Total assetsLn 16$140.1M
LiabilitiesLn 26$29.0M
PeoplePt VI, VII
31
listed · VII A
PaidVII A29
Voting boardVI 1a15
IndependentVI 1b14
2In more detail
Revenue in detailPt VIII
Gifts and grantsLn 1h$87.5M
Government grantsLn 1e$87.5M
Fees for servicesLn 2g$26.1M
Investment incomeLn 3$2.1M
Other incomeLn 4–11$170K
Gains on assetsLn 7$64K
Total revenueLn 12$115.8M
Assets in detailPt X, end of year
SavingsLn 2$52.5M
Cash and savings togetherLn 1–2$52.5M
Accounts receivableLn 4$9.1M
Inventories for sale or useLn 8$1.1M
Prepaid expenses and deferred chargesLn 9$1.7M
Land, buildings, equipmentLn 10c$43.1M
InvestmentsLn 11–13$14.5M
Other assetsLn 15$18.1M
Total assetsLn 16$140.1M
LiabilitiesLn 26$29.0M
Net assetsLn 32$111.0M
OperationsPt I, VI
EmployeesI 5497
VolunteersI 60
Fiscal year endsHeaderSeptember
Conflict-of-interest policyVI 12aYes
Whistleblower policyVI 13Yes
Records policyVI 14Yes
3More from this return
BondsSch K, Pt X
Tax-exempt bond debt owedX 20$7.0M
Bond issues listedSch K Pt I1
Raised by those issuesSch K Pt I$13.0M
4Year over year
Balance sheet, start vs end of yearPt X · col A, B
LineStart FY25End FY25
Cash and savingsLn 1–2$50.6M$52.5M
InvestmentsLn 11–13$13.7M$14.5M
Land, buildings, equipmentLn 10c$46.2M$43.1M
Total assetsLn 16$147.8M$140.1M
LiabilitiesLn 26$37.0M$29.0M
Net assetsLn 32$110.8M$111.0M
Business incomeForm 990-T, Part I
LineFY25FY24FY23
Gross$5.7M$6.5M$9.9M
Net$5.7M$6.5M$9.9M
Tax$78K$124K$80K
5Every line
Statement of functional expensesPt IX · every line
LineTotalProgramsManagementFundraising
Grants to domestic organizationsLn 1$25K$25K
Pay of officers and key staff (Part IX, line 5)Ln 5$4.7M$867K$3.9M
Other salaries and wagesLn 7$38.4M$27.7M$10.8M
Pension plan contributionsLn 8$4.1M$2.9M$1.2M
Other employee benefitsLn 9$5.5M$3.6M$1.9M
Payroll taxesLn 10$3.0M$2.1M$950K
Management feesLn 11a$0$0$0
Legal feesLn 11b$667K$240K$427K
Accounting feesLn 11c$256K$256K
Lobbying feesLn 11d$5K$5K
Investment management feesLn 11f$22K$22K
Other fees for servicesLn 11g$8.0M$4.2M$3.8M$0
Office expensesLn 13$2.2M$1.9M$271K
Information technologyLn 14$1.1M$835K$310K
OccupancyLn 16$5.9M$5.0M$814K
TravelLn 17$1.2M$791K$428K
Conferences, conventions and meetingsLn 19$265K$104K$161K
InterestLn 20$187K$158K$30K
Depreciation, depletion and amortizationLn 22$5.3M$4.8M$431K
InsuranceLn 23$438K$65K$373K
Other expenses (24a–d)Ln 24$39.3M$39.2M$30K
All other expensesLn 24e$1.2M$895K$291K$0
Total functional expensesLn 25$121.8M$95.4M$26.4M$0

Part VII lists each person's pay for the calendar year, including pay from related organizations and from people who have left; Part IX, line 5 is this organization's own cost for its current officers and key staff over its fiscal year.

The Donor report on Mriglobal

Everything above stays free. The full report adds:

  • One sourced report, every figure cited to its 990 line
  • Revenue quality
  • Compliance checks run against 4 federal lists
  • Red flags with the evaluator crosswalk
  • Peer measures

$150 one time, for this organization

Buy this report See a full sample report

Filing history

YearMoney inMoney outIn minus outNet assetsDownload
FY2025 Latest ViewingFiled with the IRS Jun 12, 2026 $115.8M$121.8M−$5.9M$111.0M 990 PDF
FY2024Filed with the IRS Aug 12, 2025 $118.0M$115.3M$2.7M$110.8M 990 PDF
FY2023Filed with the IRS Oct 27, 2025 $119.6M$112.9M$6.8M$102.8M 990 PDF
FY2022 $128.6M$121.2M$7.4M$88.2M 990 PDF
FY2021Filed with the IRS Aug 11, 2022 $116.1M$107.6M$8.5M$69.6M 990 PDF
FY2020Filed with the IRS Aug 2, 2021 $102.7M$95.1M$7.5M$51.0M 990 PDF

Schedules filed Part IV

A · Public support B · Donors C · Political and lobbying D · Assets and endowments F · Foreign I · Grants J · Pay K · Bonds O · Explanations R · Related orgs
See the full FY2025 990
Part I · Summary $115,849,749 revenue, 12 lines filed
I-8 Contributions and grantsPrior year $80,032,509$87,513,057
I-9 Program service revenuePrior year $36,342,036$26,075,073
I-10 Investment incomePrior year $1,558,270$2,155,629
I-11 Other revenuePrior year $20,137$105,990
I-12 Total revenuePrior year $117,952,952$115,849,749
I-13 Grants and similar amounts paidPrior year $25,000$25,000
I-14 Benefits paid to members$0
I-15 Salaries and benefitsPrior year $57,718,638$55,860,018
I-16a Professional fundraising fees$0
I-17 Other expensesPrior year $57,554,420$65,913,444
I-18 Total expensesPrior year $115,298,058$121,798,462
I-19 Revenue less expensesPrior year $2,654,894−$5,948,713
Part III · Program service accomplishments 3 programs, $95,436,499 spent
III-4a Integrated Defense Solutions - MRIGlobal guards human health and safety by defending against chemical, biological, and explosive threats. With decades of chemical warfare agent detection, evaluation, and assessment, our unique expertise and history combines scientific and engineering experts with state-of-the-art laboratory facilities to advance programs across the United States government and private sectors. This includes the design, building, testing, and evaluation of advanced products and technologies such as miniature devices capable of detecting toxic materials and chemical agents, field-deployable laboratories, and medical response systems that improve national defense and global health.$42,062,523
III-4b Integrated Health Surveillance and Diagnostics - MRIGlobal performs research to counter threats to human health. In our world-class laboratories, our team supports all phases of immuno and molecular assays in our CAP/CLIA certified labs. Our capabilities range from the development of cutting-edge molecular and immunological assays focused on emerging highly infectious diseases, researching vaccines and therapeutics, and the advancement of novel, highly sensitive diagnostic assays, ushering them all through regulatory clearance.includes $25,000 in grants$36,380,350
III-4c Integrated Pharmaceutical Solutions - MRIGlobal bridges the gap between drug discovery and commercialization. We provide the necessary services including development, manufacturing, testing, and clinical trial material management support for drug substances, drug products, intermediates, and impurities, including reference standard materials. Our team works in the appropriate regulatory framework, such as GLP, GMP, and in accordance with ICH guidelines to ensure strict compliance to quality and regulatory requirements. This work helps support informed public health decisions, and guiding investigational new drugs through development, clinical trials, and regulatory approvals.$16,993,626
Part IV · Checklist of required schedules 15 of 49 answered Yes, no flags
IV-1 A 501(c)(3) charity (Schedule A)Yes
IV-2 Lists its large donors to the IRS (Schedule B)Yes
IV-3 Took part in a political campaignNo
IV-4 LobbiedYes
IV-5 Owes proxy tax on member duesNo
IV-6 Holds donor advised fundsNo
IV-7 Holds conservation easementsNo
IV-8 Holds art or historical collectionsNo
IV-9 Credit counseling or escrow accountsNo
IV-10 Holds endowment fundsNo
IV-11a Reports land, buildings and equipmentYes
IV-11b Reports investments in other securitiesNo
IV-11c Reports program-related investmentsNo
IV-11d Reports other assetsYes
IV-11e Reports other liabilitiesYes
IV-11f Uncertain tax positions footnoteYes
IV-12a Its own audited financial statementsNo
IV-12b In a group's audited financial statementsYes
IV-13 Runs a schoolNo
IV-14a Has an office, staff or agents outside the USYes
IV-14b Over $10,000 of activity outside the USYes
IV-15 Over $5,000 in grants to groups abroadNo
IV-16 Over $5,000 in aid to people abroadNo
IV-17 Over $15,000 to paid fundraisersNo
IV-18 Over $15,000 from fundraising eventsNo
IV-19 Over $15,000 from gamingNo
IV-20a Runs a hospitalNo
IV-21 Over $5,000 in grants to US groupsYes
IV-22 Over $5,000 in grants to US peopleNo
IV-23 Reports top pay in detail (Schedule J)Yes
IV-24a Over $100,000 in tax-exempt bondsYes
IV-25a Gave an insider an excess benefit this yearNo
IV-25b Found an excess benefit from a past yearNo
IV-26 Loan to or from an officer or insiderNo
IV-27 Grant to an insider or their familyNo
IV-28a Business deal with an officer or directorNo
IV-28b Business deal with an officer's familyNo
IV-28c Business deal with a firm an officer controlsNo
IV-29 Over $25,000 in noncash giftsNo
IV-30 Gifts of art or historical itemsNo
IV-31 Closed down or dissolvedNo
IV-32 Sold or gave away over 25% of its net assetsNo
IV-33 Owns a single-member companyYes
IV-34 Related to other organizations (Schedule R)No
IV-35a Controls another organizationNo
IV-35b Dealings with an organization it controlsNo
IV-36 Transfers to a related non-charityNo
IV-37 Activity through a partnershipNo
IV-38 Explains answers in Schedule OYes
Part V · Other IRS filings and tax compliance no flags
V-1a Forms 1099 filed116
V-1b Forms W-2G filed0
V-2a Employees on W-2 forms497
V-1c Followed backup withholding rulesYes
V-2b Filed its payroll tax returnsYes
V-3a Over $1,000 of unrelated business incomeYes
V-3b Filed Form 990-T for that incomeYes
V-4a Holds an account in a foreign countryNo
V-5a Party to a prohibited tax shelterNo
V-5b Knew another party was in a tax shelterNo
V-6a Raised gifts that are not tax deductibleNo
V-7a Gifts where the donor got something backNo
V-7c Sold donated property it had to reportNo
V-7e Took money to pay a donor's insuranceNo
V-7f Paid premiums on a donor's insuranceNo
V-14a Sold indoor tanningNo
V-15 Owes tax on pay over $1 millionNo
V-16 Owes the college endowment taxNo
Part VI · Governance 14 of 15 board members independent, 1 to look at
VI-1a Voting members of the governing bodySchedule OThe governing body has delegated authority to act on its behalf to an Executive Committee. The Executive Committee may exercise any and all powers of the Board of Directors subject to the paramount power of the Board. The Executive Committee may convene between Board meetings to make decisions that cannot be delayed until the next Board meeting. The Executive Committee members are all voting directors. Specifically, the Executive Committee is comprised of the Chair of the Board, Vice Chair of the Board, Chair of the Finance and Audit Committee, Chair of the Nominating and Governance Committee…15
VI-1b Independent voting members14
VI-2 Family or business relationship among officers or directorsSchedule OWilliam A. Jeffrey, Ph.D. and Laura Wright - Business relationshipYes
VI-12a Written conflict of interest policyYes
VI-13 Written whistleblower policyYes
VI-14 Document retention and destruction policyYes
VI-15a Process for setting top official's paySchedule OMRIGlobal's Compensation and HR Committee (Committee) of the Board of Directors is responsible for reviewing and approving executive compensation in all areas. On an annual basis, the Committee reviews and approves compensation for executive officers of the organization. The Committee reviews and approves the CEO's performance evaluations and compensation recommendations for the executives. The Committee is informed of summary data on the organization's employee population (e.g. total personnel costs, employee diversity, turnover, etc.). The Committee utilizes compensation survey data, provid…Yes
Part VII · Officers, directors and key employees 31 people listed, 29 paid by the organization
VII-1a Ian M Colrain PHDPresident and CEO · 40 hours a week$943,691
VII-1a Martin J NevshemalCFO and Treasurer - Outgoing · 40 hours a week$509,061
VII-1a Amy M Bog PHDChief Innovation Officer · 40 hours a week$400,380
VII-1a Luke J McGlynnChief People Officer · 40 hours a week$370,224
VII-1a Jessica J ZolynasChief Legal Officer & Corp Secretary · 40 hours a week$364,629
VII-1a Dominie Garcia PHDVP-Commercial Business Development · 40 hours a week$353,318
VII-1a Joseph A Bogan JR PHDChief Research Fellow · 40 hours a week$343,045
VII-1a Michelle RodriguesVP-Government Business Development · 40 hours a week$300,450
VII-1a Richard A WinegarDistinguished Research Fellow · 40 hours a week$286,722
VII-1a Jerem G SwenddalVP-Business Ops & Strategy · 40 hours a week$275,198
VII-1a Kristine K WerkingSenior Director · 40 hours a week$264,020
VII-1a Christopher W HollarsPrincipal Advisor · 40 hours a week$234,275
VII-1a Jonathan M WhiteSenior Director · 40 hours a week$220,131
VII-1a Jason E GordonSenior Director · 40 hours a week$209,916
VII-1a Carol F BlevinsAssistant Director · 40 hours a week$194,109
VII-1a Pamela R BernekingDirector · 1 hours a week$55,000
VII-1a Amy NachtigalDirector · 1 hours a week$47,500
VII-1a David E HallDirector · 1 hours a week$47,500
VII-1a Scott M Smith PeDirector · 1 hours a week$47,500
VII-1a William A Jeffrey PHDDirector · 1 hours a week$47,500
VII-1a Alexander G Garza MD MphDirector · 1 hours a week$40,000
VII-1a Dan E Arvizu PHDDirector · 1 hours a week$40,000
VII-1a Douglas A Girod MDDirector · 1 hours a week$40,000
VII-1a Heather LeithDirector · 1 hours a week$40,000
VII-1a Julia M WilsonDirector · 1 hours a week$40,000
VII-1a Laura WrightDirector · 1 hours a week$40,000
VII-1a Neal SharmaDirector · 1 hours a week$40,000
VII-1a Steffanie B EasterDirector · 1 hours a week$40,000
VII-1a Wendy M MasielloDirector · 1 hours a week$40,000
VII-1a Josh Carpenter DphilDirector · 1 hours a week$0
VII-1a Stephanie DefinoCFO and Treasurer · 40 hours a week$0
Part VIII · Statement of revenue $115,849,749 across 7 lines filed
VIII-1e Government grants$87,513,057
VIII-1h Total contributions, gifts and grants$87,513,057
VIII-2a-f Program service revenue, itemized rows (sum of 2a–2f as filed)Related to mission $20,343,456 · Unrelated business $5,731,617 · Excluded from tax $0$26,075,073
VIII-3 Investment incomeExcluded from tax $2,092,068$2,092,068
VIII-7 Net gain or loss on sales of assetsExcluded from tax $63,561$63,561
VIII-11a-d Other revenue, itemized rows (sum of 11a–11d as filed)Excluded from tax $105,990$105,990
VIII-12 Total revenueRelated to mission $20,343,456 · Unrelated business $5,731,617 · Excluded from tax $2,261,619$115,849,749
Part IX · Statement of functional expenses $121,798,462 across 22 lines filed
IX-1 Grants to domestic organizationsPrograms $25,000$25,000
IX-5 Pay of officers and key staff (Part IX, line 5)Programs $866,558 · Management $3,862,184Part VII lists each person's pay for the calendar year, including pay from related organizations and from people who have left; Part IX, line 5 is this organization's own cost for its current officers and key staff over its fiscal year.$4,728,742
IX-7 Other salaries and wagesPrograms $27,689,443 · Management $10,751,055$38,440,498
IX-8 Pension plan contributionsPrograms $2,905,625 · Management $1,208,444$4,114,069
IX-9 Other employee benefitsPrograms $3,614,423 · Management $1,916,386$5,530,809
IX-10 Payroll taxesPrograms $2,096,267 · Management $949,633$3,045,900
IX-11a Management feesPrograms $0 · Management $0$0
IX-11b Legal feesPrograms $240,217 · Management $426,670$666,887
IX-11c Accounting feesManagement $256,286$256,286
IX-11d Lobbying feesPrograms $5,000$5,000
IX-11f Investment management feesManagement $21,879$21,879
IX-11g Other fees for servicesPrograms $4,165,329 · Management $3,831,501 · Fundraising $0$7,996,830
IX-13 Office expensesPrograms $1,890,126 · Management $270,646$2,160,772
IX-14 Information technologyPrograms $834,930 · Management $309,845$1,144,775
IX-16 OccupancyPrograms $5,044,352 · Management $814,489$5,858,841
IX-17 TravelPrograms $790,673 · Management $427,986$1,218,659
IX-19 Conferences, conventions and meetingsPrograms $103,948 · Management $160,605$264,553
IX-20 InterestPrograms $157,526 · Management $29,623$187,149
IX-22 Depreciation, depletion and amortizationPrograms $4,819,240 · Management $430,844$5,250,084
IX-23 InsurancePrograms $65,419 · Management $372,531$437,950
IX-24 Other expenses (24a–d)Programs $39,227,517 · Management $30,234$39,257,751
IX-24e All other expensesPrograms $894,906 · Management $291,122 · Fundraising $0$1,186,028
IX-25 Total functional expensesPrograms $95,436,499 · Management $26,361,963 · Fundraising $0$121,798,462
Part X · Balance sheet $140,070,332 assets, 23 lines filed
X-2 Savings and temporary cash investmentsStart of year $50,570,189$52,501,250
X-3 Pledges and grants receivableStart of year $130,451$0
X-4 Accounts receivableStart of year $12,088,081$9,083,597
X-5 Loans to officers and key peopleStart of year $0$0
X-6 Loans to other insidersStart of year $0$0
X-8 Inventories for sale or useStart of year $1,015,218$1,099,010
X-9 Prepaid expenses and deferred chargesStart of year $1,600,986$1,673,222
X-10c Land, buildings and equipment, netStart of year $46,198,090$43,101,192
X-11 Publicly traded securitiesStart of year $10,703,798$11,697,645
X-13 Program-related investmentsStart of year $2,948,972$2,824,224
X-15 Other assetsStart of year $22,572,917$18,090,192
X-16 Total assetsStart of year $147,828,702$140,070,332
X-17 Accounts payable and accrued expensesStart of year $11,379,693$11,012,295
X-20 Tax-exempt bond liabilitiesStart of year $8,245,265$6,978,347
X-22 Loans from officers and insidersStart of year $0$0
X-23 Secured mortgages and notes payableStart of year $299,742$177,791
X-24 Unsecured notes and loans payableStart of year $1,145,172$0
X-25 Other liabilitiesStart of year $15,955,846$10,868,119
X-26 Total liabilitiesStart of year $37,025,718$29,036,552
X-27 Net assets without donor restrictionsStart of year $109,182,652$110,402,386
X-28 Net assets with donor restrictionsStart of year $1,620,332$631,394
X-32 Total net assets or fund balancesStart of year $110,802,984$111,033,780
X-33 Total liabilities and net assetsStart of year $147,828,702$140,070,332
Part XI · Reconciliation of net assets $111,033,780 net assets at year end
XI-1 Total revenue$115,849,749
XI-2 Total expenses$121,798,462
XI-3 Revenue less expenses−$5,948,713
XI-4 Net assets at start of year$110,802,984
XI-5 Net unrealized gains (losses) on investments$644,521
XI-6 Donated services and use of facilities$0
XI-7 Investment expenses$0
XI-8 Prior period adjustments$0
XI-9 Other changes in net assetsSchedule OEQUITY IN EARNINGS OF ALLIANCE LLC - 5674147; PENSION ADJUSTMENT - -15157; Loss on uncollectible pledges - -18451; CHANGE IN FAIR VALUE OF INTEREST SWAP - -105551; Total - 5534988;$5,534,988
XI-10 Net assets at end of year$111,033,780
Part XII · Financial statements and reporting Audited: Yes
XII-2b Financial statements audited by an independent accountantYes
Schedule O · Explanations 9 explanations
O-1 Part VI, line 1aThe governing body has delegated authority to act on its behalf to an Executive Committee. The Executive Committee may exercise any and all powers of the Board of Directors subject to the paramount power of the Board. The Executive Committee may convene between Board meetings to make decisions that cannot be delayed until the next Board meeting. The Executive Committee members are all voting directors. Specifically, the Executive Committee is comprised of the Chair of the Board, Vice Chair of the Board, Chair of the Finance and Audit Committee, Chair of the Nominating and Governance Committee, and Chair of the Compensation and HR Committee.
O-2 Part VI, line 2William A. Jeffrey, Ph.D. and Laura Wright - Business relationship
O-3 Part VI, line 4The Bylaws were updated as follows: added narrative regarding resignation and leave of absence for directors, removed language regarding trustee as committee member, added the president as an ex officio voting member of all Board committees, corrected title of Chief People Officer, and removed references to CIO position.
O-4 Part VI, line 11bReview of 990 prior to filing the 990 is reviewed by mriglobal staff, including the CFO, controller, and chief legal officer. A final draft version is also reviewed by mriglobal's finance and audit committee. Each member of the board of directors receives a final draft version of the 990 prior to the applicable board of directors' meeting. Any updates resulting from the review by the finance and audit committee are presented to the board of directors at this meeting.
O-5 Part VI, line 12cMonitoring and Enforcement of Board Independence The officers, directors, and key employees of MRIGlobal are required to complete a disclosure statement on an annual basis. The disclosures set forth on the statements are presented to the Finance and Audit Committee of the MRIGlobal Board of Directors by the MRIGlobal Compliance Officer. The Finance and Audit Committee discusses the disclosure statements to determine if any potential conflict-of-interest situations exist with respect to the officers, directors, and key employees of MRIGlobal. At the following MRIGlobal Board meeting, an executive summary of the disclosure statements is presented to the Directors and the Finance and Audit Committee reports the outcome of its discussion to the Directors. The Directors are presented the opportunity to discuss the Finance and Audit Committee's findings or any other potential conflict-of-interest issues presented in the executive summary. Ultimately, the Board of Directors will determine whether a conflict of interest exists with respect to any officer, director, or key employee of MRIGlobal. The Finance and Audit Committee's findings and the Directors' discussion of potential conflict-of-interest situations are recorded in the minutes of the Board meeting, including determination of whether a conflict of interest exists, the names of the individuals involved, the nature of the potential conflict, the action taken, and the basis on which the Board reached its decision. MRIGlobal has certain procedures with respect to addressing a conflict-of-interest transaction. Any action to be taken by MRIGlobal involving or pertaining to an individual, entity or circumstance with respect to which an officer, director, or key employee (each, a covered person) has a conflicting interest will be discussed and voted on by the Board of Directors. The covered person will leave the meeting during the discussion of, and the vote on, the transaction or arrangement that may result in a conflict of interest. In considering any such action to be taken, the Board will undertake appropriate due diligence and inform itself of all material information reasonably available to it and explore all reasonable alternatives to the proposed action that would not involve the conflict of interest. The standard for the determination of whether to undertake the proposed action is whether such action is, based on a reasonable good-faith belief, (I) in MRIGlobal's best interest, (II) for its own benefit, and (III) fair and reasonable to MRIGlobal. The Board will document whether or not the conflict-of-interest transaction was approved, the names of the persons present for the discussion and vote, the content of the discussion, whether alternatives were discussed that did not involve a conflict of interest, the basis for the determination that the transaction was (I) in MRIGlobal's best interest, (II) for its own benefit, and (III) fair and reasonable to MRIGlobal, and the record of the vote taken with respect to who voted to approve the transaction. If the Board has reasonable cause to believe that a covered person has failed to disclose a conflict-of-interest situation, it will afford the covered person an opportunity to explain the alleged failure to disclose. If, after hearing the response of the covered person and making such further investigation as may be warranted under the circumstances, the Board determines that the covered person has in fact failed to disclose a conflict-of-interest situation, it will take appropriate corrective actions. The MRIGlobal conflict-of-interest policy requires that the officers, directors, and employees of MRIGlobal disclose any potential conflict-of-interest situation to the appropriate party, including an employee's supervisor, a representative of Human Resources, the Compliance Officer, the Board of Directors, or the MRIGlobal Ethics Hotline, upon awareness that a conflict of interest may exist. Potential conflict-of-interest situations associated with employees (other than officers, directors, and key employees) are handled by the MRIGlobal Compliance Officer, in collaboration with the employee's supervisor and MRIGlobal Executive Management, as appropriate. All MRIGlobal employees are required on an annual basis to complete a compliance questionnaire, which affords them the opportunity to disclose any potential conflict-of-interest situations that have not already been reported or to certify that they are not aware of any potential conflict-of-interest situations. Failure to disclose a potential conflict of interest situation may result in corrective action to the employee.
O-6 Part VI, line 15aMRIGlobal's Compensation and HR Committee (Committee) of the Board of Directors is responsible for reviewing and approving executive compensation in all areas. On an annual basis, the Committee reviews and approves compensation for executive officers of the organization. The Committee reviews and approves the CEO's performance evaluations and compensation recommendations for the executives. The Committee is informed of summary data on the organization's employee population (e.g. total personnel costs, employee diversity, turnover, etc.). The Committee utilizes compensation survey data, provided by an outside party, to benchmark compensation against similarly situated companies. The Committee's minutes document the decisions and basis used for MRIGlobal's executive compensation.
O-7 Part VI, line 15bSee response for Part VI, Line 15a
O-8 Part VI, line 19Governing documents, conflict of interest policy, financial statements - mriglobal's governing documents and financial statements are made available to the public upon request. Mriglobal's conflict-of-interest policy is not made available to the public.
O-9 Part XI, line 9EQUITY IN EARNINGS OF ALLIANCE LLC - 5674147; PENSION ADJUSTMENT - -15157; Loss on uncollectible pledges - -18451; CHANGE IN FAIR VALUE OF INTEREST SWAP - -105551; Total - 5534988;

Form 990 e-file FY2025 from the IRS (about our sources) · Classification, formation year and address from the IRS Business Master File

Similar: Future Earth · Global Science & Envirotech · Science Council for Global Initiatives Incorporated · Sustainable Obtainable Solutions · Engineers for a Sustainable World · Association of Global Intelligent Science and Technology

Similar organizations you could support · Compare with another nonprofit

The names, titles, and financial information shown on this page are reproduced from IRS Form 990 filings, which are public records. More

Philanthropy.org does not alter the content of those filings. All information appears exactly as reported by the filing organization for the tax year shown. A filing can only be corrected by the organization filing an amended return with the IRS; the corrected information appears here at our next update.

We publish only information contained in the public IRS filing, and less than the filing contains. Our pages do not display home addresses, telephone numbers, personal email addresses, or other personal contact information, even where the filing includes them.

Many people share the same name. A name shown on this page reflects only what one organization reported in one IRS filing for one tax year. It should not be interpreted as identifying any other individual with the same or a similar name.

If you are no longer affiliated with the organization, your name will generally stop appearing in future IRS filings once the organization no longer reports you. Pages for tax years in which you were reported remain published because those filings remain part of the public record.

Philanthropy.org does not alter or remove IRS filing records. Removing a page from this website would not remove the underlying IRS filing, which remains publicly available from the IRS and other publishers of the same information.

If you believe the IRS filing itself is inaccurate, contact the filing organization or the IRS directly.

Featured nonprofit jobs

All nonprofit jobs → · Hiring? Post a job →

Get Science & Technology jobs in Missouri by email

Jobs
Hiring?
Post a job: $199 for 30 days.
Post a job
Reach nonprofit leaders here.
Sponsor this page →

All figures come from public IRS Form 990 filings. Comparisons are computed from the filing against similar orgs. They are not a rating.